178 related articles for article (PubMed ID: 36078038)
21. Arid1a mutation suppresses TGF-β signaling and induces cholangiocarcinoma.
Guo B; Friedland SC; Alexander W; Myers JA; Wang W; O'Dell MR; Getman M; Whitney-Miller CL; Agostini-Vulaj D; Huber AR; Mello SS; Vertino PM; Land HK; Steiner LA; Hezel AF
Cell Rep; 2022 Aug; 40(9):111253. PubMed ID: 36044839
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
Kimura A; Arakawa N; Hirano H
J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
[TBL] [Abstract][Full Text] [Related]
23. The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling.
Cui H; Yi H; Bao H; Tan Y; Tian C; Shi X; Gan D; Zhang B; Liang W; Chen R; Zhu Q; Fang L; Gao X; Huang H; Tian R; Sperling SR; Hu Y; Chen W
Nat Commun; 2022 Aug; 13(1):4680. PubMed ID: 35945219
[TBL] [Abstract][Full Text] [Related]
24. Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription.
Blümli S; Wiechens N; Wu MY; Singh V; Gierlinski M; Schweikert G; Gilbert N; Naughton C; Sundaramoorthy R; Varghese J; Gourlay R; Soares R; Clark D; Owen-Hughes T
Cell Rep; 2021 Nov; 37(5):109943. PubMed ID: 34731603
[TBL] [Abstract][Full Text] [Related]
25. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
26. ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis.
Shang XY; Shi Y; He DD; Wang L; Luo Q; Deng CH; Qu YL; Wang N; Han ZG
Cell Death Dis; 2021 Oct; 12(11):990. PubMed ID: 34689165
[TBL] [Abstract][Full Text] [Related]
27. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
28. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.
Alpsoy A; Dykhuizen EC
J Biol Chem; 2018 Mar; 293(11):3892-3903. PubMed ID: 29374058
[TBL] [Abstract][Full Text] [Related]
29. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.
Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A
Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099
[TBL] [Abstract][Full Text] [Related]
30. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
31. The Chromatin Remodeling Component Arid1a Is a Suppressor of Spontaneous Mammary Tumors in Mice.
Kartha N; Shen L; Maskin C; Wallace M; Schimenti JC
Genetics; 2016 Aug; 203(4):1601-11. PubMed ID: 27280691
[TBL] [Abstract][Full Text] [Related]
32. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A
Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909
[TBL] [Abstract][Full Text] [Related]
33. ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies.
Caumanns JJ; Wisman GBA; Berns K; van der Zee AGJ; de Jong S
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):176-184. PubMed ID: 30025943
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency.
Wang J; Yan HB; Zhang Q; Liu WY; Jiang YH; Peng G; Wu FZ; Liu X; Yang PY; Liu F
Oncogene; 2021 Sep; 40(36):5468-5481. PubMed ID: 34290402
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
[TBL] [Abstract][Full Text] [Related]
36. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
[TBL] [Abstract][Full Text] [Related]
37. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
38. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
39. HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A.
Van Rechem C; Boulay G; Leprince D
Biochem Biophys Res Commun; 2009 Aug; 385(4):586-90. PubMed ID: 19486893
[TBL] [Abstract][Full Text] [Related]
40. SWI/SNF chromatin-remodeling factor Smarcd3/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling.
Jordan NV; Prat A; Abell AN; Zawistowski JS; Sciaky N; Karginova OA; Zhou B; Golitz BT; Perou CM; Johnson GL
Mol Cell Biol; 2013 Aug; 33(15):3011-25. PubMed ID: 23716599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
